1 Pulmonary Vein İsolation with the Cryoballoon: Simpler, Faster But Equally Effective? Gian Battista Chierchia M.D., Antonio Sorgente M.D., Fatih Bayrak M.D., Andrea Sarkozy M.D., Carlo De Asmundis M.D., Pedro Brugada M.D. Heart Rhythm Management Centre, Uz Brussel-vub, Brussels, Belgium ABSTRACT Atrial Fibrillation (AF) is the most frequently encountered arrhythmia in clinical practice that represents an enormous burden for our current health care systems. Since the demonstration of pulmonary vein (PV) ectopic activity as the main trigger of paroxysmal AF, radiofrequency ablation (RF) of this arrhythmia has become an increasingly popular procedure in many electrophysiology laboratories. Nowadays creation of circumferential lesions around the PVs is certainly the most widespread technique to achieve PV isolation. Recently, novel balloon shaped ablation catheters have proven very effective in producing PV isolation with the added potential ability of achieving complete circular lesions with a single application. However, the cryoballoons currently available do not always adapt themselves well to the anatomical variants and do not systematically isolate the PVs in one application. Ideally, a more compliant balloon which would fit into most PVs might lead to a more effective procedure. Future technological improvements might lead a larger number of electrophysiologists to adopt such a technique. KEYWORDS Ablation, atrial fibrillation, catheter, cryoballoon, isolation, pulmonary vein
2 62 Türk Aritmi, Pacemaker ve Elektrofizyoloji Dergisi Kriyobalon ile Pulmoner Ven İzolasyonu: Basit, Hızlı... Fakat Eşit Etkili mi? ÖZET Atriyal fibrilasyon klinik uygulamada en sık karşılaşılan aritmidir ve sağlık sistemi üzerine önemli bir yük getirmektedir. Pulmoner venlerdeki (PV) ektopik aktivitenin paroksizmal AF için ana tetikleyici olduğu gösterilmesiyle bu aritminin radyofrekans (RF) ablasyonu birçok elektrofizyoloji laboratuvarında popüler bir işlem haline gelmiştir. Günümüzde PV izolasyonunda dairesel lezyonların PV etrafında oluşturulması en yaygın tekniktir. Son zamanlarda yeni balon şeklindeki ablasyon kateterlerinin etkili PV izolasyonunda tek uygulama ile tam dairesel lezyon oluşturma başarıları kanıtlanmıştır. Bununla birlikte halen kullanılan kriyobalonlar anatomik çeşitliliğe tam uyum göstermemekte ve tek uygulama ile sistematik olarak PV ler izole edilememektedir. PV lere daha iyi uyum sağlayan balonlar daha etkili olabilir. Gelecek teknolojik ilerlemeler çok sayıda elektrofizyologun böyle tekniklere uyum sağlamasına neden olabilir. ANAHTAR KELİMELER Ablasyon, atriyal fibrilasyon, kateter, kriyobalon, izolasyon, pulmoner ven İLETİŞİM ADRESİ Gian Battista Chierchia MD Heart Rhythm Management Centre UZ Brussel-VUB Laarbeeklaan 101, 1090 Brussels, Belgium Introduction Atrial Fibrillation (AF) is the most frequently encountered arrhythmia in clinical practice that represents an enormous burden for our current health care systems. Since the demonstration of pulmonary vein (PV) ectopic activity as the main trigger of paroxysmal AF (1,2), radiofrequency ablation (RF) of this arrhythmia has become an increasingly popular procedure in many electrophysiology laboratories. Nowadays creation of circumferential lesions around the PVs is certainly the most widespread technique to achieve PV isolation. In most centers, this procedure is achieved by performing a point by point lesion that renders the creation of continuous lines difficult and permits the formation of electrical gaps which may lead to arrhythmic recurrence (3). Additionally even in experienced hands this approach is still too cumbersome (4). Furthermore, AF ablation using RF is associated with a certain number of serious complications such as PV stenosis, thrombo-embolism, pericardial tamponade, and atrio-oesophageal fistula (4). Recently, novel balloon shaped ablation catheters have proven very effective in producing PV isolation with the added potential ability of achieving complete circular lesions with a single application (5). Among the latter, the Cryo-
3 Pulmonary Vein İsolation with the Cryoballoon: Simpler, Faster But Equally Effective? 63 balloon (Arctic Front, Medtronic, USA) using cryothermal energy ablation, is certainly the one that has awoken the most interest in the Electrophysiologist Community (5). Not only does it reliably achieve the ultimate goal of PV isolation but, by the fact of using cryothermal energy, the procedure might be safer due to less thrombogenic lesions and potentially associated with a lower risk of PV stenosis than RF energy (6,7,8). Due to its relatively uncomplicated procedure, an increasing number of electrophysiology laboratories might choose the cryoballoon as the standard tool ablation for PV isolation in the near future. The Cryothermal Balloon Device This tool (Fig 1) represents a very appealing system to perform PV isolation being able to produce electrical isolation with virtually one single application. Mainly designed to approach drug resistant paroxysmal AF, the cryoballoon therapy apparatus include the Arctic Front doubled-walled cryoballoon catheter, which inflates and fills with coolant (N 2 O) to ablate between the pulmonary veins and the left atrium; the FlexCath Steerable Sheath, which helps deliver and position the cryocatheter in the left atrium (LA) and the CryoConsole, which houses the coolant, electrical and mechanical components that run the catheter during a cryotherapy procedure. The refrigerant N 2 O is delivered into the balloon where it undergoes a liquid-togas phase change, resulting in cooling temperature of approximately -80 C. As other cryothermal tools the endocardial lesion created by the cryoballoon occurs in three main phases. The first phase is characterized by the immediate effect of freezing on the cardiac tissue by the formation of ice crystals in both the extracellular and intracellular space. When reaching temperatures lower than -20/-25 C ice cristal formation occurs in the extracellular space. Further ablation reaching temperatures lower than -40 C leads to cellular damage by the means of intracellular ice cristal formation. This phenomenon provokes destruction of cytoplasmic organels and architectural subversion of the cell membrane. Irreversible cellular death will occur when temperatures reach values lower than -70 C. When cryothermal energy is stopped, a rapid vasodilatation and a state of augmented vascular permeability lead to hemorrage and edema with further tissue injury. During this hyperemic response endothelial damage results in platelet aggregation and microthrombus formation with microcirculation stagnation for roughly 30 to 45 min. The third phase is characterized by scar formation. During the latter, tissue repairment occurs by collagen deposits, fatty infiltrations and neovascularisation. The fibrotic scar will first develop from the peripheric areas of the lesion eventually reaching the centre (9,10). The cryoballoon catheter has a central lumen, which can be used for different scopes such as the insertion of the guide wire, the injection of contrast medium (diluted 1:1 ratio FİGURE 1 The cryoballoon catheter
4 64 Türk Aritmi, Pacemaker ve Elektrofizyoloji Dergisi FİGURE 2 The Achieve inner lumen mapping catheter(black arrow) permits real time recordings of PV potentials when inserted into the veins ostia through the cryoballoon (white arrow) lumen. with 0.9% saline) for PV angiograms and eventually the insertion of a circular mapping catheter to evaluate PV isolation during cryothermal energy application (8). Navigation of the balloon inside the LA is simplified using the overthe-wire technique in addition to the steerable sheath (12 F, FlexCath, Medtronic Cryocath TM, USA). In addition, the cryoballoon itself is steerable thanks to a pull wire mechanism integrated in the handle of the catheter itself. catheter (Achieve, Medtronic, USA) is positioned in the PV ostium to gather real time recordings (Fig 2). The balloon is then inflated and advanced over the circular mapping catheter in the PV ostium of each vein. Optimal vessel occlusion is considered to have been achieved when selective contrast injection shows total contrast retention with no flow to the atrium. If occlusion is not possible using the circular mapping catheter, the latter can be exchanged with a guide wire that might offer better stability. For each vein, cryoablation usually consists of a minimum of 2 applications lasting 5 minutes each. Whenever possible, the operator tries to engage with the guide-wire 2 different branches of the same vein and to orient the balloon differently, in the attempt of covering a wider ostial surface. However, if successful occlusion could only be obtained in one branch, both applications are delivered by leaving the guide-wire in the same branch. Usually, the left superior PV (LSPV) (Fig 3) is The Procedure Usually a single transseptal puncture is then performed using the right femoral venous approach. In some centers, a double transseptal puncture is achieved in order to have simultaneous electrical information during the freezing phase. After gaining the LA access, a 70 IU/Kg heparin iv bolus is given and afterwards repeated to maintain the activated clotting time over 300 s. Selective PV angiograms are then performed. Immediately after, a steerable 15 F over-the-wire sheath (FlexCath, Cryocath, Medtronic, USA) is positioned in the LA. Through the latter, a 23 or 28 mm double walled cryoballoon (Arctic Front, Medtronic, USA) is up to the LA. An inner lumen circular mapping FİGURE 3 Successful occlusion of the LSPV with the cryoballoon demonstrated by total retention of contrast inside the vein.
5 Pulmonary Vein İsolation with the Cryoballoon: Simpler, Faster But Equally Effective? 65 treated first, followed by the left inferior PV (LIPV), right superior PV (RSPV) and right inferior PV (RIPV). During ablation, the circular mapping catheter offers real time information of the electrical activity in the vein. Usually, PV isolation can be observed real-time during energy delivery. In order to avoid phrenic nerve palsy, a complication observed during cryoballoon ablation in the RSPV and RIPV, a bipolar catheter is inserted in the superior vena cava in order to pace phrenic nerve with a 1000 ms cycle and a 20 ma pulse output. Diaphragmatic contraction during pacing will indicate correct phrenic capture. If this contraction suddenly stops or weakens, the cryoablation should be immediately interrupted. The reason of pacing at such a slow rate is to prevent catheter displacement in the early phases of application due to diaphragmatic contraction. In case of persistence of PV potentials extra cryoballoon applications were performed until complete PV isolation. In case of failure of the cryoballoon, a focal RF or cryothermal energy catheter is used to complete PV isolation. In clinical practice isolating the inferior PVs can be particularly challenging in comparison to the superior ones (11). Specifically, occluding and isolating the RIPV is often quite tricky due to the proximity of this vein to the site of transatrial access and its posterior orientation, especially in patients with relatively small LA (LA diameter < 35 mm). Various ablation techniques aiming at overcoming these anatomical obstacles have been reported : the hockey stick technique, the pull-down technique. The hockey stick technique is applied in patients with an early branching inferior PV and consists of a maximal bending of the sheath towards the superior-posterior LA, allowing the cryoballoon to be pushed and to adhere to inferior part of the PV ostium. The RIPV can be addressed using the pull-down technique. This procedure consists in starting the freeze at the ostium of the PV, regardless of the incomplete occlusion and when the latter adheres to the interpulmonary carina (typically at -20 C) to pull down all the cryoballoon apparatus, in order to close the inferior gap. Pulmonary Vein İsolation: Acute Results According to recent publications about PV isolation can be demonstrated in more than 90% of veins following cryoballoon ablation. Successful PV isolation with the cryoballoon is highly dependent on a perfect contact to the atrial wall at the level of the PV ostia Indeed, lack of blood back-flow allows the cryoballoon to obtain lower temperatures with the result of achieving more deeper lesions (12). Anatomical difficulties seem to represents the main obstacle to complete PV isolation when using the cryoballoon; Van Belle et al. reported that oval shaped PV ostia or veins inserting into the LA with a sharp angulation are the most difficult to occlude (12). However like in all other techniques, the learning curve and the level of the operator s experience will condition the efficacy of cryoballoon ablation. Our group analyzed the degree of adenosine induced LA-PV isolation following cryoballoon ablation (13). Adenosine is known to induce transient reconduction in isolated PVs, due to incomplete lesions after RF ablation (14,15). In our series of patients, transient PV-LA reconnection occurred only in 4,6% PVs compared to a mean 30% of veins following PV isolation with RF. A possible explanation of this discrepancy is that a balloon strategy might lead to more continuous lesions than point by point circumferential PV isolation.
6 66 Türk Aritmi, Pacemaker ve Elektrofizyoloji Dergisi Pulmonary Vein İsolation: Chronic Results Fürnkranz and colleagues (16) analyzed the sites of PV reconnection in 26 patients undergoing repeat ablation for recurrent symptomatic AF or atrial tachycardia after initial cryoballoon ablation for paroxysmal AF. They found a high rate of PV reconnection (around 50%) at a median follow-up of about 6 months. Reconnection mostly occurred in the inferior segments of the inferior PVs and on the LA appendix -LSPV ridge. They postulated, in accordance to the previous findings described by others (12) that a straighter alignment of the balloon with the superior PVs as compared with the inferior ones provides more contact force on the LA wall and lower temperatures. Accordingly to these findings, Ahmed and coworkers evidenced at 8-12 weeks months follow up that 88% of PVs previously ablated with the cryoablation therapy were still isolated and that reconnections occurred mainly in the LIPV and in the inferior aspects of each vein (17). Both groups of authors underlined the importance of full PV occlusion during cryoablation. Follow-Up Unfortunately, data on follow-up of patients having undergone AF ablation is extremely heterogeneous and varies immensely from center to center. The success rates following AF ablation on the long-term should thus be interpreted with extreme caution. However, data available in the literature reports promising results. Klein et al (18) first reported the success rate of cryoballoon ablation at 6 months. In their study up to 86% of patients were AF free on a short term follow-up. Neumann et al, rounding up the biggest series up to now, obtained at 1 year a success rate of 74% (5). Kühne et al.(19) reported a success rate of 71% at 1 year follow up too. Linhart and colleagues, which compared cryoballoon ablation to RF in a small series of patients (20), found a deceiving success rate of about 50% at 1 year of follow-up. However as the authors explained this finding with the fact that the blanking period in their study was of only 4 weeks. Additionally, many AF recurrences following the cryoballoon ablation occurred immediately after the procedure and decreasingly lowered in the following observational period. Adverse Events Phrenic Nerve Palsy (PNP) Cryoablation is historically known as a safe ablative energy source. However, it is also the procedure known to be mostly associated with PNP among all the PV isolation techniques. Although mostly associated with the 23 mm balloon, PNP has been demonstrated during ablation with the bigger balloon as well. Luckily, it is in nearly all cases a transient phenomenon that reverts spontaneously. According to the recently presented STOP AF data at the American College of Cardiology 2010, this complication occurred in 11% of the 228 patients studied (21). Fortunately in 98,2% of patients the complication spontaneously resolved. A recent publication, (20) comparing cryoballoon technology with RF ablation in a group of patients affected by paroxysmal AF, right PNP occurred in about 11% of patients undergoing cryoballoon ablation and all these cases resolved spontaneously. Interestingly, all of them were associated with the use of a 23 mm cryoballoon. This could be explained by the fact that the smaller cryoballoon might achieve a more distal lesion occurring closer to the phrenic nerve s anatomical course.
7 Pulmonary Vein İsolation with the Cryoballoon: Simpler, Faster But Equally Effective? 67 PV Stenosis Only the data presented on the STOP AF (21) reported PV stenosis as a possible collateral effect of cryoballoon ablation. In fact, the rate of PV stenosis was 3.1% versus a complete absence of this complication in the already published reports. This difference might be explained by the fact that in the STOP AF trial the PV stenosis was intensively investigated during the follow-up and that the definition of PV stenosis was quite strict. Esophageal Lesions More interestingly, atrio-esophageal fistula has never been described among procedural complications of cryoballoon ablation. Esophageal lesions following cryoballoon ablation is another matter of debate. In fact, whereas Fürnkranz et al.(22) demonstrated that PV isolation with the cryoballoon was not associated with thermal esophageal lesions in any of 38 studied patients, Ahmed et al.(23) on the contrary showed appearance of transient esophageal ulcerations in 17% of the patients following this procedure. Interestingly, a correlation with temperature changes inside the esophageal lumen was found by the authors. Pericardial Effusion Pericardial effusion is another potentially life threatening complication observed associated to AF ablation. Our group (24) compared the incidence and clinical outcome of pericardial effusion following cryoballoon ablation and RF ablation. A total of 133 consecutive patients with paroxysmal AF were included in this study. Pericardial effusion was detected in 14.2% of the 133 patients. Sixteen patients presented mild effusion, one moderate effusion, and 2 pericardial tamponades(related to transseptal puncture). Interestingly, there was no significant difference in the incidence of pericardial effusion between the cryoballoon and the RF group (11 vs. 16%). Fortunately, pericardial effusion was mostly mild and asymptomatic, with benign clinical outcome not requiring additional hospitalization days. Cerebral Embolisation Cryoablation is known to be associated to less thrombus formation. However the recent MEDAFI study (25), not only reported a 14% of new cerebral lesions following ablation but, more importantly showed no significant difference in this event between patients undergoing ablation with RF or Cryoballoon. Luckily, all these neurological lesions proved to be asymptomatic. However, it does proove that the anticoagulation strategy when working in the LA with any tool is of utmost importance. Conclusion Cryoballoon ablation is a very promising technique to treat AF. However, the cryoballoons currently available do not always adapt themselves well to the anatomical variants and do not systematically isolate the PVs in one application. Ideally, a more compliant balloon which would fit into most PVs might lead to a more effective procedure. Future technological improvements will certainly overcome some of the abovementioned issues and might lead a larger number of electrophysiologists to adopt such a technique. The future randomized trials such as the ongoing Freeze AF trial (26) will certainly provide valuable answers to the most important issue: can cryoballoon reach the goal of becoming the gold standard for PV isolation? For the moment, this role is still played by point by point RF circumferential PV isolati-
8 68 Türk Aritmi, Pacemaker ve Elektrofizyoloji Dergisi on in most Electrohysiology Laboratories. Conflicts of interests: Dr GB Chierchia has received compensation as a proctor for AF Solutions Medtronic. REFERENCES 1. Natale A, Raviele A, Arentz T, et al. Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 2007;18: Haissaguerre M, Jaı s P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339: Ouyang F, Bansch D, Ernst S, et al. Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-lasso technique in paroxysmal atrial fibrillation. Circulation 2004;110: Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3: Neumann T, Vogt J, Schumacher B, et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol ;52: Khairy P, Chauvet P, Lehmann J, et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 2003;107: Tse HF, Reek S, Timmermans C, et al. Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis. J Am Coll Cardiol 2003;42: Chun KR, Fürnkranz A, Metzner A, et al. Cryoballoon pulmonary vein isolation with realtime recordings from the pulmonary veinsj Cardiovasc Electrophysiol. 2009;20: Atienza F, Almendral J, Sanchez-Quintana D, et al. Cryoablation time-dependent dose-response effect at minimal temperatures(_8à degrees C): an experimental study. Europce.2009;11: Dubuc M, Roy D, Thibault B, Ducharme A, et al. Transvenous catheter ice mapping and cryoablationof the atrioventricular node in dogs. Pacing Clin Electrophysiol.1999;22: Chun KR, Schmidt B, Metzner A, et al. The single big cryoballoon technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J. 2009;30: Van Belle Y, Janse P, Rivero-Ayerza MJ, et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur Heart J. 2007;28: Chierchia GB, Yazaki Y, Sorgente A, et al. Transient atriovenous reconnection induced by adenosine after successful pulmonary vein isolation with the cryothermal energy balloon. Europace. 2009;11: Arentz T, Macle L, Kalusche D, et al. Dormant pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2004;15: Tritto M, De Ponti R, Salerno-Uriarte JA, et al. Adenosine restores atrio-venous conduction after apparently successful ostial isolation of the pulmonary veins. Eur Heart J 2004;25: Fürnkranz A, Chun KR, Nuyens D, et al. Characterization of conduction recovery after pulmonary vein isolation using the single big cryoballoon technique. Heart Rhythm. 2010;7: Ahmed H, Neuzil P, Skoda J, et al.the Permanency of Pulmonary Vein Isolation Using a Balloon Cryoablation Catheter. J Cardiovasc Electrophysiol in press. 18. Klein G, Oswald H, Gardiwal A, et al. Efficacy of pulmonary vein isolation by cryoballoon ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm. 2008;5: Kühne M, Schaer B, Ammann P, Suter Y, Osswald S, Sticherling C. Cryoballoon ablation for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Swiss Med Wkly. 2010;140: Linhart M, Bellmann B, Mittmann-Braun E, et al. Comparison of cryoballoon and radiofrequency ablation of pulmonary veins in 40 patients with paroxysmal atrial fibrillation: a case-control study. J Cardiovasc Electrophysiol. 2009;20: Packer D. Abstract presented at ACC Fürnkranz A, Chun KR, Metzner A, et al. Esophageal endoscopy results after pulmonary vein isolation using a single big cryoballoon technique. J Cardiovasc Electrophysiol. 2010;21: Ahmed H, Neuzil P, d Avila A, et al. The esophageal effects of cryoenergy during cryoablation for atrial fibrillation. Heart Rhythm 2009;6: Chierchia GB, Capulzini L, Droogmans S, et al. Pericardial effusion in atrial fibrillation ablation: a comparison between cryoballoon and radiofrequency pulmonary vein isolation. Europace. 2010;12: Neumann T, Kuniss M, Conradi G, et al. MEDAFI-Trial (Micro-embolization during ablation of atrial fibrillation): comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy. Europace. 2011;13: Luik A, Merkel M, Hoeren D, Riexinger T, Kieser M, Schmitt C. Rationale and design of the FreezeAF trial: a randomized controlled noninferiority trial comparing isolation of the pulmonary veins with the cryoballoon catheter versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation. Am Heart J 2010;159:
References 1 Sarabanda AV, Bunch TJ, Johnson SB, et al. Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. J Am Coll Cardiol. November 15,
Ablation For Atrial Fibrillation Bill Petrellis Electrophysiologist AF is the most common arrhythmia in the Western world Prevalence 1.1% in Australia conservative estimate - 240,000 June 2009 AF is an
September 2008 CT of the Left Atrium and Pulmonary Veins before Radio- Frequency Catheter Ablation for Atrial Fibrillation Vincent Chen, Harvard Medical School Year IV Agenda Our patient Atrial fibrillation
www.icrj.ir Review Ablation of Atrial Fibrillation: Patient Selection, Techniques, and the Outcome A Arya Department of Electrophysiology, University of Leipzig, Heart Center, Leipzig, Germany Introduction
Ashley Chin Cardiac Electrophysiologist Groote Schuur Hospital UCT Private Academic Hospital Pathogenesis of AF Focal triggers and a susceptible substrate -> AF Pulmonary veins are the crucial source of
Combined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation Ashkan Babaie MD Providence Portland Medical Center 1 Disclosures None 2 Cox-Maze III The Godfather Cure rates > 95% in
Brief Statement Refer to the device technical manual for detailed information regarding the procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events.
Catheter Ablation of Valvular Atrial Fibrillation Rong Bai, MD, FESC, FHRS Beijing Anzhen Hospital, Capital Medical University Beijing, China NO CONFLICT OF INTEREST TO DECLARE How to define valvular atrial
The Decision Tree for Ablation Therapy in Atrial Fibrillation Colin Movsowitz, MD, FACC Cardiology Consultants of Philadelphia Director of Electrophysiology Einstein Medical Center Montgomery Co-Director
Isolation Of The Left Atrial Appendage: Techniques And Safety Luigi Di Biase, MD, J. David Burkhardt, MD, Prasant Mohanty, MD, Javier E. Sanchez, MD, Mitra Mohanty, MD, Rodney Horton, MD, G. Joseph Gallinghouse,
Corporate Medical Policy Catheter Ablation as a Treatment for Atrial Fibrillation File Name: Origination: Last CAP Review: Next CAP Review: Last Review: catheter_ablation_as_a_treatment_for_atrial_fibrillation
CATHETER ABLATION for ATRIAL FIBRILLATION Atrial Fibrillation Clinic Dr. Richard Leather, Dr. Larry Sterns, Dr Paul Novak, Dr. Chris Lane Royal Jubilee Hospital Block 3 rd floor, Rm 343 1952 Bay Street
Progress in Atrial Fibrillation Ablation? Why are we having this discussion? Laurent Lewkowiez, MD Director Cardiac Electrophysiology St. Joseph s Cardiac and Vascular Institute Clinical Assistant Professor
The durability of pulmonary vein isolation using the visually guided laser balloon catheter: Multicenter results of pulmonary vein remapping studies Srinivas R. Dukkipati, MD,* Petr Neuzil, MD, PhD, Josef
TREATMENT UPDATE Pulmonary Vein Isolation for Atrial Fibrillation David Keane, MD, PhD, Jeremy Ruskin, MD Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA Nonpharmacological treatment
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence
Europace (215) 17, 1596 16 doi:1.19/europace/euv2 EP WIRE Current techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey Nikolaos Dagres 1 *, Maria Grazia
Aus dem Deutschen Herzzentrum Berlin Klinik für Innere Medizin/Kardiologie DISSERTATION Techniques of Mapping and Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation zur Erlangung des
Hellenic J Cardiol 45: 250-255, 2004 Review Risks and Complications of Catheter Ablation of Atrial Fibrillation: How Do We Avoid Them? SAKIS THEMISTOCLAKIS, ALDO BONSO, ANTONIO ROSSILLO, ANTONIO RAVIELE
Ablation Therapy in Atrial Fibrillation Patients Sandeep K. Jain, M.D. Associate Professor of Medicine Director, UPMC Passavant Cardiac Electrophysiology Co-Director, Center for Atrial Fibrillation University
IRREGULAR HEARTBEAT? Get your rhythm back. ABOUT ARRHYTHMIA If you ve been diagnosed with a cardiac arrhythmia, there has been a change from the normal sequence of electrical impulses in your heart, causing
Treatments to Restore Normal Rhythm In many instances when AF causes significant symptoms or is negatively impacting a patient's health, the major goal of treatment is to restore normal rhythm and prevent
Catheter Ablation as Treatment Page 1 of 29 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Catheter Ablation as Treatment Professional Institutional Original Effective
Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study
Catheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation Policy Number: Original Effective Date: MM.06.011 09/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration
ATRIAL FIBRILLATION ABLATION WHAT IS ATRIAL FIBRILLATION? Atrial fibrillation (AF) is a rapid and irregular rhythm disturbance of the upper chambers of the (atria) heart overriding the normal heart pacemaker.
Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of
Original Issue Date (Created): April 26, 2011 Most Recent Review Date (Revised): January 27, 2015 Effective Date: April 1, 2015 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
Name of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation Policy #: 283 Latest Review Date: June 2015 Category: Medical Policy Grade: A Background/Definitions:
Introduction to Electrophysiology Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center Objectives Indications for EP Study How do we do the study Normal recordings Abnormal Recordings Limitations
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
Rome, Italy December 4-7, 2012 Rome Cavalieri Monday, December 3 ROOM Terrazza Monte Mario PATIENT MANAGEMENT CONCEPTS AND CONTROVERSIES IN ELECTROPHYSIOLOGY BIOTRONIK International Fellows Program (IFP)
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial Lucas Boersma, WimJan van Boven, Alaaddin Yilmaz, Johannes Kelder, Maurits Wijffels
PREVENTION OF ATRIAL FIBRILLATION PROGRESSION BY CATHETER ABLATION Turin, 13 th October 2016 Prof. Fiorenzo Gaita Cardiovascular Department Director, University of Turin, Italy Atrial Fibrillation Begets
The Role of Catheter Ablation in the Management of Ventricular Tachycardia Hugh Calkins M.D. Professor of Medicine Director of Electrophysiology The Johns Hopkins Medical Institutions Cardiology Update
Cardiac rate control or rhythm control could be the key to AF therapy Recent studies have proven that an option of pharmacologic and non-pharmacologic therapy is available to patients who suffer from AF.
Section Four: Pulmonary Artery Waveform Interpretation All hemodynamic pressures and waveforms are generated by pressure changes in the heart caused by myocardial contraction (systole) and relaxation/filling
CT for Electrophysiology Applications Harold Litt MD-PhD Associate Professor of Radiology and Medicine, Chief, Cardiovascular Imaging Section, Department of Radiology Perelman School of Medicine of the
Ablation of Paroxysmal and Persistent Atrial Fibrillation J.A. Salerno-Uriarte, M. Lanzotti, R. De Ponti, M. Tritto*, G. Spadacini*, R. Marazzi, P. Moretti* Università degli Studi dell'insubria, Dipartimento
Catheter Ablation A Guided Approach for Treating Atrial Arrhythmias A P A T I E N T H A N D B O O K This brochure will provide an overview of atrial arrhythmias (heart rhythm problems affecting the upper
Knowledge is Power! In order to help you make the best decisions about AF ablation, we want you to be knowledgeable about your AF and our ablation outcomes The following presentation provides information
case of severe bradycardia caused by premature atrial beats Gi-young Nam, MD Department of Internal Medicine, University of Ulsan ollege of Medicine, san Medical enter, Seoul, Korea STRT The standard management
Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città
Cryoballoon Pulmonary Vein Isolation for the Treatment of Atrial Fibrillation and Issues in Follow-up Management Yves Van Belle Cryoballoon Pulmonary Vein Isolation for the Treatment of Atrial Fibrillation
Atrial Fibrillation and Ablation Therapy: A Patient s Guide ATRIAL FIBRILLATION CENTER AT UNIVERSITY OF ROCHESTER MEDICAL CENTER www.heart.urmc.edu 585-275-4775 INTRODUCTION Our goal at the Atrial Fibrillation
CATHETER ABLATION for PAROXYSMAL ATRIAL FIBRILLATION Vancouver Island Arrhythmia Clinic (VIAC) Dr. Richard Leather, Dr. Larry Sterns, Dr Paul Novak 335-1900 Richmond Ave Victoria, B.C. V8R 4R2 (250) 595-1551
Tigullio 2012, 16-18 Febbraio, S. Margherita Ligure La terapia anticoagulante orale dopo ablazione della FA: pro e contro Antonio Raviele, MD, FESC, FHRS Ex Direttore Dipartimento Cardiovascolare, Ospedale
Radiofrequency Ablation for Atrial Fibrillation A Guide for Adults Fast Facts n There are different ways to treat atrial fibrillation (A-fib). One kind of treatment involves putting the heart back into
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department
NONSURGICAL INTRAVENOUS CATHETER TREATMENT FOR ATRIAL FIBRILLATION SUFFERERS ST. LUKE S-ROOSEVELT HOSPITAL, NEW YORK, NY BROADCAST DATE MARCH 3, 2004 NARRATOR The American Heart Association estimates that
UW MEDICINE PATIENT EDUCATION Supraventricular Tachycardia (SVT) and Ablation Treating your abnormal heart rhythm This handout describes a type of abnormal heart rhythm called supraventricular tachycardia.
2016 CODING AND REIMBURSEMENT Cardiac Surgical Ablation & Left Atrial Appendage Management Introduction This information is for educational purposes and current as of January 2016. Healthcare providers
2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.
Powered by TCPDF (www.tcpdf.org) This is a provisional PDF only. Copyedited and fully formatted version will be made available soon. ONLINE FIRST ISSN: 1897-5593 e-issn: 1898-018X Learning curve in circular
Improved Resource Utilization With Similar Efficacy During Early Adoption of Cryoballoon Pulmonary Vein Isolation as Compared to Radiofrequency Ablation for Paroxysmal Atrial Fibrillation Donald Siddoway,
My life has taken a turn for the better. AF Answers A Patient Education Handbook on Electrophysiology My episodes of atrial fibrillation (AF) kept me from fully enjoying what I was accustomed to doing.
Sizing Balloon II Instructions for Use Device Description The AMPLATZER Sizing Balloon II is a triple lumen balloon catheter with three (3) radiopaque marker bands located inside the balloon to allow for
SECTION I: Request This is a formal request for the Utah CARMA Center to be formally recognized by the University of Utah as a large, collaborative medical and academic center whose focus is on comprehensive
My follow-up questions: Global Headquarters Cardiac Rhythm One St. Jude Medical Drive Management Division St. Paul, Minnesota 55117 15900 Valley View Court USA Sylmar, California 91342 + 1 651 756 2000
(20219) Medical Benefit Effective Date: 07/01/12 Next Review Date: 03/15 Preauthorization No Review Dates: 05/09, 03/10, 03/11, 03/12, 03/13, 03/14 The following Protocol contains medical necessity criteria
Atrial Fibrillation Ablation: State of the Art Carlo Pappone, MD, PhD,* and Vincenzo Santinelli, MD Among several catheter-based strategies for curing atrial fibrillation (AF), 2 approaches have emerged
Intuitive 3D catheter guidance Philips EP navigator and 3D rotational scan 3D - efficiently and accurately guide your catheter For patients with symptomatic paroxysmal atrial fibrillation (AF) who do not
Rhythm control strategies for symptomatic atrial fibrillation Hemels, Martin Eric Willem IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.
Contact Us For additional information or to schedule an appointment with one of our specialists, please call: Ken Ellenbogen, M.D. Cardiology/Electrophysiology 804-828-7565 or 804-628-0147 You can also
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Hot Line Session at European Society of Cardiology (ESC) Congress 2014: Once-Daily
OHTAC Recommendation: Endovascular Ablation for Varicose Veins Ontario Health Technology Advisory Committee July 2013 Background Health Quality Ontario (HQO) reviewed Endovascular Laser Therapy for Varicose
Circulatory System Obj: Explain the structure of the heart 1 Structure of the Heart Size, shape and location 1. Size of a closed fist 2. In thoracic cavity 3. Apex: the tip of the heart that lies on the
A Patient Guide to Atrial Fibrillation and Catheter Ablation Al-Sabah Arrhythmia Institute 1111 Amsterdam Avenue New York, NY 10025 Phone: 212-523-2400 Fax: 212-523-2571 www.stlukescardiology.org Printed
Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.
Atrial fibrillation How is treatment changing? Charles Henrikson, MD Director, Electrophysiology Service 1 February 2014 Outline Introduction Natural history of afib and stroke Current risk stratification
Thrombolysis, thromboaspiration, ultrasound thrombectomy: adjuncts techniques for aorto-iliac recanalization. Dr. S. Schepers Dr. F. Van Elst Sint-Trudo Hospital Sint-Truiden Belgium Chronic aorto-iliac
PATIENT INFORMATION GUIDE TO ATRIAL FIBRILLATION A Comprehensive Resource from the Heart Rhythm Society AF 360 provides a single, trusted resource for the most comprehensive and relevant information and
How do you decide on rate versus rhythm control? Dr. Mark O Neill Consultant Cardiologist & Electrophysiologist Assumptions Camm et al. EHJ 2010;Sept 25 epub Choice of strategy: Criteria for consideration
Patient information factsheet Tachyarrhythmias (fast heart rhythms) The normal electrical system of the heart The heart has its own electrical conduction system. The conduction system sends signals throughout
What are the surgical options to treat atrial fibrillation? New concepts for the surgical treatment of atrial fibrillation were introduced in recent years when the surgical device industry introduced different
Catheter Ablation of the Pulmonary Veins as Treatment for Atrial Fibrillation Policy Number: Original Effective Date: MM.06.011 09/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO 05/25/2012
Comparative Effectiveness of Interventions for Secondary Prevention of Atrial Fibrillation Following Ablation Larisa Tereshchenko, MD, PhD Rationale for trial: Atrial fibrillation (AF) is associated with
Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia
III. Cell destruction by freezing and cryoprobe development 1 WHAT IS CRYOSURGERY? Cryoprobe Surface iceball formation Ice-ball Cryoprobe Cryosurgery of liver (Angular insertion) Cryosurgery of liver (Vertical
2012 ACCF/AHA/HRS Guidelines for Implantable Defibrillator and Cardiac Resynchronization for Cardiac Rhythm Abnormalities 1 Despite ICD and CRT being a Class I or IIa indication for treatment of patients,